ResearcherHeliopolis UniversityNo recent work listed

Tohada M. AL‐Noshokaty

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5449-7089; OpenAlex author ID A5036217477. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 2 papers

Papers 2

Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. Co-author DOI 10.1016/j.prp.2023.154438 ↗
Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer. Co-author DOI 10.1016/j.prp.2023.154855 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shereen Saeid Elshaer · 2 shared papers, 2023 · strength 0.35
- Paper Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. DOI 10.1016/j.prp.2023.154438 ↗
- Paper Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resi… DOI 10.1016/j.prp.2023.154855 ↗
Ahmed I. Abulsoud · 2 shared papers, 2023 · strength 0.35
- Paper Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. DOI 10.1016/j.prp.2023.154438 ↗
- Paper Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resi… DOI 10.1016/j.prp.2023.154855 ↗
Ahmed Soliman Doghish · 2 shared papers, 2023 · strength 0.35
- Paper Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. DOI 10.1016/j.prp.2023.154438 ↗
- Paper Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resi… DOI 10.1016/j.prp.2023.154855 ↗
Hesham A. El‐Mahdy · 1 shared paper, 2023 · strength 0.17
- Paper Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resi… DOI 10.1016/j.prp.2023.154855 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.